Skip to content
  • Science
  • About Us
  • News
  • Publications
  • Investors
  • Contact Us
  • Science
  • About Us
  • News
  • Publications
  • Investors
  • Contact Us
Contact Us

Type: Publication

The Relation of Circulating CC16 to Lung Function Growth, Decline, and Development of COPD Across the Lifespan

Background Low serum levels of the anti-inflammatory club cell secretory protein (CC16) have been associated with an accelerated FEV1 decline in COPD. Whether low circulating CC16 precedes lung function deficits and incidence of COPD in the general population is unknown. Methods We used longitudinal data from adults who were COPD-free at baseline from the population-based […]

← Previous

Revolutionizing Treatment for Obstructive Lung Diseases

Sitemap
  • Home
  • Science
  • About Us
  • News
  • Investors
  • Home
  • Science
  • About Us
  • News
  • Investors
Become an Investor

Email in*******@******tx.com today for more information, or visit our website to stay updated on Aspiro Therapeutics’ growth.

Get In Touch

in**@******tx.com
760.659.0779
Tucson, AZ 85704

© 2025 Aspiro Therapeutics. All Rights Reserved. Marketing by SCAD Media

Linkedin X-twitter